Papers

1

Total Citations

15

H-Index

1

About

Dana Alhattab is a pioneering researcher at the intersection of tissue engineering and oncology, whose work centers on developing advanced 3D bioprinting platforms to model hematological malignancies. Her primary research areas include biomaterials science, automated bioprinting technologies, and the creation of physiologically relevant in vitro disease models. Alhattab’s most notable contribution is the fabrication of a three-dimensional bone marrow niche-like acute myeloid leukemia (AML) disease model, achieved through an automated, controlled process using a robotic multicellular bioprinting system. This groundbreaking work, published in 2023 and already garnering 15 citations, addresses a critical gap in cancer research by providing a robust preclinical platform that faithfully mimics the bone marrow microenvironment. By enabling the study of AML resistance mechanisms and facilitating the testing of novel therapies, her model holds significant promise for reducing disease relapse rates. Alhattab’s innovative approach combines cutting-edge automation with biological complexity, positioning her as a key figure in the development of next-generation disease models. Her achievements underscore a commitment to translating engineering solutions into tangible advances in cancer biology and personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: King Abdullah University of Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago